Cargando…

Cardiovascular medicine in China: what can we do to achieve the Healthy China 2030 plan?

Cardiovascular diseases (CVDs) represent the leading cause of death in China. The Chinese government approved the Healthy China 2030 plan (jiànkāng zhōngguó 2030), emphasizing the strategic role of health in China’s development. As morbidity and mortality from CVDs are constantly increasing in China...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bei, Yihua, Yang, Tingting, Xiao, Junjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107941/ https://www.ncbi.nlm.nih.gov/pubmed/30139358 http://dx.doi.org/10.1186/s12916-018-1133-4

Ejemplares similares

The Importance of Reducing Smoking in China: To Achieve Healthy China 2030 While Reducing the Severity of the COVID-19 Pandemic
por: Fong, Geoffrey T., et al.
Publicado: (2020)

Prevention and Treatment of Pneumoconiosis in the Context of Healthy China 2030
por: Wang, Huanqiang, et al.
Publicado: (2023)

Achieving the Goals of Healthy China 2030 Depends on Increasing Smoking Cessation in China: Comparative Findings from the ITC Project in China, Japan, and the Republic of Korea
por: Fong, Geoffrey T., et al.
Publicado: (2021)

Healthy China 2030: a missed opportunity for injury control
por: Ning, Peishan, et al.
Publicado: (2017)

What can we do about osteoarthritis?
por: Lohmander, L Stefan
Publicado: (2000)

Suicide epidemic in Malawi: what can we do?
por: Banda, Gift Treighcy, et al.
Publicado: (2021)

Can we do for other essential medicines what we are doing for the COVID-19 vaccine?
por: Murphy, Adrianna, et al.
Publicado: (2021)

Long COVID: Does It Exist? What Is It? We Can We Do For Sufferers?
por: Hoffer, Edward P.
Publicado: (2021)

Tobacco control and Healthy China 2030
por: Goodchild, Mark, et al.
Publicado: (2019)

Assessing outcomes of health and medical research: do we measure what counts or count what we can measure?
por: Wells, Robert, et al.
Publicado: (2007)

Time-restricted feeding: what we have done and what more we can do?
por: Sun, Yuning, et al.
Publicado: (2023)

Limited Funds for Bladder Cancer Research and What Can We Do About It
por: Boormans, Joost L., et al.
Publicado: (2016)

Sodium and brain injury: do we know what we are doing?
por: Zygun, David A
Publicado: (2009)

Understanding the lingering consequences of what we treat and what we do
por: Angus, Derek C
Publicado: (2004)

How will we do mathematics in 2030?
por: Douglas, Michael
Publicado: (2021)

Health Education in the Healthy China Initiative 2019−2030
por: Jiang, Zhuojun, et al.
Publicado: (2021)

The Inclusion of Chiropractic Care in the Healthy China Initiative 2030
por: Chu, Eric Chun-Pu, et al.
Publicado: (2023)

How Can We Achieve Good Compliance for Bowel Preparation?
por: Park, Jongha, et al.
Publicado: (2019)

Vita activa in biotechnology: what we do with fungi and what fungi do with us
por: Weinhold, Martin, et al.
Publicado: (2017)

Interpretation of Healthy Diet Campaign in Healthy China Initiative 2019–2030
por: Wang, Liusen, et al.
Publicado: (2021)

Can China achieve a one-third reduction in premature mortality from non-communicable diseases by 2030?
por: Li, Yichong, et al.
Publicado: (2017)

What Do We Demand? Responding to the Call for Precision and Definitional Agreement in Family Planning’s “Demand” and “Need” Jargon
por: Fabic, Madeleine Short
Publicado: (2022)

The WSES: what do we see in the future?
por: De Simone, Belinda, et al.
Publicado: (2021)

Closing the gap to achieve HBV elimination by 2030: A global pursuit fueled by regional successes
por: Wong, Robert J.
Publicado: (2021)

Tight glycemic control: what do we really know, and what should we expect?
por: Nasraway, Stanley A, et al.
Publicado: (2010)

Ocular surface inflammation in dry eye disease: What we know and what we do not
por: Vazirani, Jayesh
Publicado: (2018)

What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review
por: Sun, Jing, et al.
Publicado: (2021)

Combating hepatitis B and C by 2030: achievements, gaps, and options for actions in China
por: Chen, Shu, et al.
Publicado: (2020)

The pervasive issue of racism and its impact on infertility patients: what can we do as reproductive endocrinologists?
por: Ibrahim, Yetunde, et al.
Publicado: (2020)

Pharmacy Internships: We Can Do Better
por: Nisly, Sarah, et al.
Publicado: (2018)

Early goal-directed therapy: what do we do now?
por: Levy, Mitchell M
Publicado: (2014)

Research in health policy making in China: out-of-pocket payments in Healthy China 2030
por: Fu, Wei, et al.
Publicado: (2018)

Research in health policy making in China: out-of-pocket payments in Healthy China 2030
Publicado: (2018)

Endotracheal tube leak: What should we do?
por: Gupta, Nishkarsh
Publicado: (2015)

Allied health growth: what we do not measure we cannot manage
por: Solomon, Daniela, et al.
Publicado: (2015)

Maintenance of physical activity: Do we know what we are talking about?
por: Kahlert, Daniela
Publicado: (2015)

National Action Plan for Dog-Mediated Rabies Elimination: A One Health Approach to Catalytic Response is Key to India Achieving the Target by 2030
por: Dasgupta, Rajib, et al.
Publicado: (2023)

Healthy People 2030: A Call to Action to Lead America to Healthier Lives
por: Giroir, Brett P.
Publicado: (2021)

Healthy People 2030: A Beacon for Addressing Health Disparities and Health Equity
por: Levine, Rachel L.
Publicado: (2021)

Enhancer RNA: What we know and what we can achieve
por: Han, Zhenzhen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q11s8l6tieqc7on0lsv9an232g